257 related articles for article (PubMed ID: 15121858)
1. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.
Takenaka Y; Fukumori T; Yoshii T; Oka N; Inohara H; Kim HR; Bresalier RS; Raz A
Mol Cell Biol; 2004 May; 24(10):4395-406. PubMed ID: 15121858
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest.
Yoshii T; Fukumori T; Honjo Y; Inohara H; Kim HR; Raz A
J Biol Chem; 2002 Mar; 277(9):6852-7. PubMed ID: 11724777
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
Fukumori T; Oka N; Takenaka Y; Nangia-Makker P; Elsamman E; Kasai T; Shono M; Kanayama HO; Ellerhorst J; Lotan R; Raz A
Cancer Res; 2006 Mar; 66(6):3114-9. PubMed ID: 16540661
[TBL] [Abstract][Full Text] [Related]
4. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.
Cecchinelli B; Lavra L; Rinaldo C; Iacovelli S; Gurtner A; Gasbarri A; Ulivieri A; Del Prete F; Trovato M; Piaggio G; Bartolazzi A; Soddu S; Sciacchitano S
Mol Cell Biol; 2006 Jun; 26(12):4746-57. PubMed ID: 16738336
[TBL] [Abstract][Full Text] [Related]
5. Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells.
Pokrywka M; Bubka M; Janik M; Pocheć E; Hoja-Łukowicz D; Lityńska A
Cell Biol Int; 2016 Apr; 40(4):428-38. PubMed ID: 26800112
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the nuclear import pathways of galectin-3.
Nakahara S; Oka N; Wang Y; Hogan V; Inohara H; Raz A
Cancer Res; 2006 Oct; 66(20):9995-10006. PubMed ID: 17047062
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST).
Lee KK; Yonehara S
J Biol Chem; 2002 Apr; 277(14):12351-8. PubMed ID: 11805089
[TBL] [Abstract][Full Text] [Related]
8. The role of galectin-3 in cancer drug resistance.
Fukumori T; Kanayama HO; Raz A
Drug Resist Updat; 2007 Jun; 10(3):101-8. PubMed ID: 17544840
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
Shalom-Feuerstein R; Cooks T; Raz A; Kloog Y
Cancer Res; 2005 Aug; 65(16):7292-300. PubMed ID: 16103080
[TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2.
Kumari G; Mahalingam S
Exp Cell Res; 2009 Oct; 315(16):2775-90. PubMed ID: 19555684
[TBL] [Abstract][Full Text] [Related]
11. Transport of galectin-3 between the nucleus and cytoplasm. II. Identification of the signal for nuclear export.
Li SY; Davidson PJ; Lin NY; Patterson RJ; Wang JL; Arnoys EJ
Glycobiology; 2006 Jul; 16(7):612-22. PubMed ID: 16473834
[TBL] [Abstract][Full Text] [Related]
12. Importin-mediated nuclear translocation of galectin-3.
Nakahara S; Hogan V; Inohara H; Raz A
J Biol Chem; 2006 Dec; 281(51):39649-59. PubMed ID: 17056590
[TBL] [Abstract][Full Text] [Related]
13. Why anti-Bcl-2 clinical trials fail: a solution.
Harazono Y; Nakajima K; Raz A
Cancer Metastasis Rev; 2014 Mar; 33(1):285-94. PubMed ID: 24338002
[TBL] [Abstract][Full Text] [Related]
14. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
Wang D; You D; Li L
J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
[TBL] [Abstract][Full Text] [Related]
17. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
Gong HC; Honjo Y; Nangia-Makker P; Hogan V; Mazurak N; Bresalier RS; Raz A
Cancer Res; 1999 Dec; 59(24):6239-45. PubMed ID: 10626818
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis.
Bartholomeusz G; Wu Y; Ali Seyed M; Xia W; Kwong KY; Hortobagyi G; Hung MC
Mol Carcinog; 2006 Feb; 45(2):73-83. PubMed ID: 16302269
[TBL] [Abstract][Full Text] [Related]
19. Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner.
Berbís MÁ; André S; Cañada FJ; Pipkorn R; Ippel H; Mayo KH; Kübler D; Gabius HJ; Jiménez-Barbero J
Biochem Biophys Res Commun; 2014 Jan; 443(1):126-31. PubMed ID: 24269589
[TBL] [Abstract][Full Text] [Related]
20. Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import.
Davidson PJ; Li SY; Lohse AG; Vandergaast R; Verde E; Pearson A; Patterson RJ; Wang JL; Arnoys EJ
Glycobiology; 2006 Jul; 16(7):602-11. PubMed ID: 16473835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
